Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.
第一单位:
Unit for Clinical Research on Addictions, Oslo University Hospital, PO Box 4959 Nydalen, Oslo, 0424, Norway. linwus@ous-hf.no.;Norwegian Centre for Addiction Reasearch, Institute of Clinical Medicine, University of Oslo, PO Box 1039 Blindern, Oslo, 0315, Norway. linwus@ous-hf.no.
作者:
医学主题词
人类(Humans);血清流行病学研究(Seroepidemiologic Studies);男(雄)性(Male);女(雌)性(Female);成年人(Adult);抗体, 病毒(Antibodies, Viral);中年人(Middle Aged);前瞻性研究(Prospective Studies);挪威(Norway);免疫, 体液(Immunity, Humoral);吸毒者(Drug Users);抗体, 中和(Antibodies, Neutralizing);疫苗, 合成(Vaccines, Synthetic);队列研究(Cohort Studies)
DOI
10.1186/s12954-024-01023-9
PMID
38890611
发布时间
2024-08-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



